Related Experiment Video
Updated: Jun 28, 2025

09:24
Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
4.4K
Machine learning for identifying tumor stemness genes and developing prognostic model in gastric cancer
Guo-Xing Li1, Yun-Peng Chen2, You-Yang Hu2
1Department of Oncology and Central Laboratory, Tumor Hospital Affiliated to Nantong University, Nantong, Jiangsu 226361, P.R. China.
Aging
|April 13, 2024
Summary
This study identifies key genes driving tumor stemness in gastric cancer, developing a prognostic model to predict patient outcomes and guide personalized treatment strategies for this challenging disease.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Gastric cancer poses significant challenges due to treatment resistance and recurrence.
- Tumor stem cells are implicated in gastric cancer progression and therapeutic failure.
- Identifying genes related to tumor stemness is crucial for improving patient outcomes.
Purpose of the Study:
- To identify key genes associated with tumor stemness in gastric cancer.
- To develop a prognostic model for gastric cancer patients based on tumor stemness genes.
- To investigate the role of identified genes in gastric cancer malignancy and immune infiltration.
Main Methods:
- Utilized ssGSEA, WGCNA, and machine learning to identify tumor stemness key genes (TSKGs).
- Constructed the Tumor Stemness Risk Genes Prognostic Model (TSRGPM) and assessed its prognostic value using PCA, Cox regression, and ROC analysis.
- Analyzed immune infiltration patterns with CIBERSORT and validated findings through in vitro experiments.
Main Results:
- Developed the TSRGPM, demonstrating its efficacy in risk stratification and as an independent prognostic indicator for gastric cancer.
- Found a significant correlation between Tumor Stemness Risk Scores (TSRS) and lymph node metastasis.
- Identified CDC25A as a key gene promoting malignant phenotype, cell proliferation, and DNA replication, validated by in vitro studies.
Conclusions:
- The TSRGPM provides a promising tool for gastric cancer prognostication.
- Identified CDC25A as a potential therapeutic target for gastric cancer.
- The study advances personalized management strategies for gastric cancer by elucidating tumor stemness mechanisms.

